截至招股说明书签署日，巨化集团有限公司(以下简称"巨化集团")直接持有锦华新材80,837,240股股 份，持股比例为82.49%，为锦华新材控股股东。 浙江省人民政府国有资产监督管理委员会(以下简称"浙江省国资委")直接持有巨化集团76.49%股份，通 过杭州钢铁集团有限公司间接持有巨化集团13.51%股权，共计持有巨化集团90.00%股权。浙江省国资 委为浙江省人民政府直属正厅级特设机构，省政府授权省国资委代表省政府履行国有资产出资人职责， 监管省属经营性国有资产。因此，锦华新材的实际控制人为浙江省国资委。 中国经济网北京7月5日讯北京证券交易所上市委员会2025年第13次审议会议于昨日上午召开，审议结果 显示，浙江锦华新材料股份有限公司(以下简称"锦华新材")符合发行条件、上市条件和信息披露要求。 这是今年过会的第31家企业(其中，上交所和深交所一共过会19家，北交所过会12家)。 锦华新材的保荐人、主承销商为浙商证券（601878）股份有限公司，签字保荐代表人为苗淼、廖来泉。 这是浙商证券今年保荐成功的第1单IPO项目。 锦华新材主要从事酮肟系列精细化学品的研发、生产和销售，主要产品包括硅烷交联剂、羟 ...

Core Viewpoint - Zhejiang Jinhua New Materials Co., Ltd. has received approval for its IPO application from the Beijing Stock Exchange, indicating a significant step towards public listing and potential capital raising for business expansion [1]. Group 1: Company Overview - The company primarily engages in the research, production, and sales of ketoxime series fine chemicals, including silane crosslinking agents, hydroxylamine salts, methoxyamine hydrochloride, and acetaldehyde oxime [4]. - Jinhua New Materials is recognized as a leading enterprise in the domestic market for silane crosslinking agents and hydroxylamine salts [4]. - The company was established in December 2007 and transitioned to a joint-stock company in July 2009, with a total share capital of 98 million shares prior to the IPO [4]. Group 2: Shareholding Structure - The controlling shareholder of the company is Juhua Group Co., Ltd., which holds 82.49% of the shares. The actual controller is the Zhejiang Provincial State-owned Assets Supervision and Administration Commission, which directly holds 76.49% of Juhua Group and indirectly holds 13.51% through Hangzhou Steel Group Co., Ltd., totaling 90.00% ownership of Juhua Group [5]. Group 3: Financial Performance - During the reporting period, the company's operating revenues were 993.97 million yuan, 1,114.51 million yuan, and 1,239.48 million yuan, respectively. The net profit attributable to the parent company, excluding non-recurring gains and losses, was 78.42 million yuan, 172.81 million yuan, and 205.83 million yuan [6]. Group 4: Inquiry Issues Raised - Questions were raised regarding the authenticity and reasonableness of the operating performance, particularly concerning the differences in gross profit margins across sales channels and the authenticity of terminal sales by traders [7]. - The company was asked to clarify its operational independence from the controlling shareholder, Juhua Group, in terms of assets, personnel, finance, and business operations [7]. - Concerns were also expressed about environmental compliance and safety production, specifically regarding whether overcapacity has led to environmental pollution and whether the internal control mechanisms for environmental compliance and safety production are effective [7].

Core Viewpoint - Zhejiang Jinhua New Materials Co., Ltd. (Jinhua New Materials) is preparing for its listing on the Beijing Stock Exchange, focusing on the production and sales of fine chemical products, particularly oxime series chemicals. The company has shown revenue growth in recent years, but its profitability remains a concern due to a significant drop in gross margin and net profit compared to 2021 [2][4][5]. Financial Performance - Jinhua New Materials reported revenues of 9.94 billion, 11.15 billion, and 12.39 billion for 2022, 2023, and 2024 respectively, with net profits of 0.78 billion, 1.73 billion, and 2.06 billion [4][5]. - The company’s revenue in 2021 was 11.53 billion, indicating a decline in 2022 by 1.59 billion. The net profit in 2021 was 2.45 billion, which is more than three times the profit in 2022 [4][5]. - Gross margin dropped from 34.12% in 2021 to 17.72% in 2022, rebounding to 27.65% in 2023, but still below the 2021 level [5][6]. Industry Comparison - Jinhua New Materials' gross margin has consistently been lower than its peers. In 2022, the average gross margin for comparable companies was 34.59%, while Jinhua's was only 17.72% [6][7]. - The gross margin for Jinhua's main product, silane crosslinking agents, was 16.21% in 2022, significantly lower than the average of 34.88% for similar products from competitors [8][9]. Related Procurement and Financial Concerns - The company has faced scrutiny regarding the fairness of its related-party procurement, particularly concerning the pricing of raw materials [3][10]. - The proportion of receivables settled through bank acceptance bills increased significantly in 2024, raising concerns about the authenticity of the company's financial performance [3][12]. - Jinhua New Materials' cash flow from operating activities has shown significant volatility, with a notable decline of 68.74% in 2024 compared to 2023 [10][12]. Conclusion - Jinhua New Materials is experiencing a recovery in revenue but faces challenges in profitability and cash flow management. The reliance on bank acceptance bills for settlements and the low gross margins compared to industry peers raise questions about the sustainability of its financial performance [15].

Core Viewpoint - The company, Zhejiang Jinhua New Materials Co., Ltd., is preparing for an IPO on the Beijing Stock Exchange, aiming to raise funds for several high-value projects in the fine chemical sector, particularly in silane crosslinking agents and ketoxime products [1][3]. Group 1: Company Overview - Jinhua New Materials specializes in the research, production, and sales of ketoxime series fine chemicals, with key products including silane crosslinking agents, hydroxylamine salts, methoxyamine hydrochloride, and acetaldehyde oxime [3]. - The company is a leading player in the domestic market for silane crosslinking agents and hydroxylamine salts, with market shares projected to grow from 28.30% in 2021 to 37.34% in 2024 [3]. Group 2: Financial Performance - The company experienced significant revenue and profit fluctuations in recent years, with revenues of 1153.26 million yuan in 2021, dropping to 993.97 million yuan in 2022, and then recovering to 1239.48 million yuan in 2024 [5]. - Net profits after deducting non-recurring gains and losses were 244.65 million yuan in 2021, falling to 78.42 million yuan in 2022, and rising to 205.83 million yuan in 2024 [5]. - The gross profit margin showed volatility, with rates of 34.12% in 2021, 17.72% in 2022, and recovering to 27.94% in 2024 [5]. Group 3: Market Demand and Growth Drivers - The increase in net profit for 2023 is attributed to higher production capacity of silane crosslinking agents and growing market demand from downstream products like organic silicone sealants and adhesives in sectors such as photovoltaic, wind power, and new energy vehicles [5]. - A decrease in raw material and energy prices, along with improvements in production processes, contributed to a significant reduction in unit costs and an increase in gross profit margins [5]. Group 4: Corporate Structure and Relationships - The controlling shareholder of Jinhua New Materials is Juhua Group Co., Ltd., which holds 82.49% of the shares, while the actual controller is the Zhejiang Provincial State-owned Assets Supervision and Administration Commission [6]. - The company has a close business relationship with Juhua Group, with significant amounts of related party transactions for energy, raw materials, and processing services, accounting for 35.43% to 37.52% of total procurement in recent years [8].

Core Viewpoint - The article discusses the upcoming IPO of Zhejiang Jinhua New Materials Co., Ltd., highlighting its position in the fine chemical products industry and its growth potential backed by strong market demand and strategic partnerships [2][4][8]. Group 1: Company Overview - Zhejiang Jinhua New Materials Co., Ltd. focuses on the research, production, and sales of ketoxime series fine chemicals, including silane crosslinking agents, hydroxylamine salts, methoxyamine hydrochloride, and acetaldehyde oxime [4]. - The company is a leading player in the domestic silane crosslinking agent and hydroxylamine salt segments, with market shares projected to grow from 28.30% in 2021 to 37.34% in 2024 for silane crosslinking agents [4][6]. Group 2: Financial Performance - The company experienced revenue and profit fluctuations in recent years, with revenues of 1153.26 million yuan in 2021, dropping to 993.97 million yuan in 2022, and then recovering to 1239.48 million yuan in 2024 [6]. - Net profits after excluding non-recurring gains and losses were 244.65 million yuan in 2021, falling to 78.42 million yuan in 2022, and expected to rise to 205.83 million yuan in 2024 [6]. - The gross profit margin showed volatility, with figures of 34.12% in 2021, dropping to 17.72% in 2022, and recovering to 27.94% in 2024 [6]. Group 3: Market Demand and Growth Drivers - The increase in production capacity for silane crosslinking agents and the growing market demand for end products like organic silicone sealants and adhesives in sectors such as construction, photovoltaic, wind power, electronics, and new energy vehicles are key growth drivers [6]. - The company benefits from reduced raw material and energy costs, along with improved production processes, leading to a significant decrease in unit costs and an increase in gross profit margins [6]. Group 4: Strategic Relationships - The company is closely linked to its controlling shareholder, Juhua Group, which holds 82.49% of its shares, and is ultimately controlled by the Zhejiang Provincial State-owned Assets Supervision and Administration Commission [8][10]. - The company has significant business interactions with Juhua Group, with related party procurement amounts reaching 305.50 million yuan in 2021, accounting for 37.26% of total procurement [10].

Core Viewpoint - Zhejiang Jinhua New Materials Co., Ltd. (Jinhua New Materials) is preparing for its listing on the Beijing Stock Exchange, with Zheshang Securities as the sponsor. The company specializes in the research, production, and sales of ketoxime series fine chemicals, positioning itself as a leader in the domestic silane crosslinking agents and hydroxylamine salts sectors [1][3]. Company Overview - Jinhua New Materials primarily produces silane crosslinking agents, hydroxylamine salts, methoxyamine hydrochloride, and acetaldehyde oxime, which are essential for various applications including organic silicon sealants, pesticides, and environmentally friendly dyes [1]. - The actual controller of the company is the Zhejiang State-owned Assets Supervision and Administration Commission, indicating a transition from a private enterprise to a state-owned enterprise [3][5]. Shareholder Structure - As of the prospectus disclosure date, the company had four shareholders: Juhua Group (82.49%), Lishui Jinhong (10.66%), Fujian Shenyuan (3.57%), and Hong Gen (3.28%) [3]. - The second-largest shareholder, Lishui Jinhong, is an employee stock ownership platform, with significant holdings by management [7]. Fundraising and Financial Performance - The company plans to raise 593 million yuan (approximately 59.3 million) through its IPO, with a reduction of 175 million yuan from the initial target of 767.8 million yuan [9][10]. - The funds will be allocated to projects including a 60kt/a high-end coupling agent project, a 500 tons/year JH-2 pilot project, and the construction of a ketoxime industry chain smart factory [9][12]. - Jinhua New Materials has experienced significant revenue fluctuations, with reported revenues of 994 million yuan, 1.115 billion yuan, and 1.239 billion yuan for the years 2022 to 2024, respectively [16]. Customer and Supplier Relationships - The company relies heavily on a few major customers, with the top five clients accounting for over 50% of total revenue. The largest customer is a company controlled by Hong Gen's brother, indicating potential conflicts of interest [17][19]. - Jinhua New Materials' largest supplier is Juhua Group, which has provided a significant portion of the company's procurement needs over the past three years [22][24]. Research and Development - The company's R&D expenses have been lower than the industry average, with R&D expense ratios of 4.84%, 4.46%, and 4.62% over the past three years, compared to higher rates from competitors [24][26].